Prediction of survival benefit using an automated bone scan index in patients with castration-resistant prostate cancer
Author:
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2012.11355.x/fullpdf
Reference26 articles.
1. EAU guidelines on prostate cancer;Heidenreich;Eur Urol,2008
2. Prognostic value of bone scan in patients with metastatic prostate cancer treated initially with androgen deprivation therapy;Rigaud;J Urol,2002
3. Costs of prostate cancer, metastatic to the bone, in the Netherlands;Groot;Eur Urol,2003
4. Docetaxel based chemotherapy as second-line chemotherapy-resistant hormone refractory prostate cancer: a pilot study;Urakami;Urology,2005
5. Phase-II study of docetaxel, estramustine phosphate, and carboplatin in patients with hormone-refractory prostate cancer;Kikuno;Eur Urol,2007
Cited by 69 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer;JCO Precision Oncology;2024-02
2. Quantitative assessment of PSMA PET response to therapy in castration-sensitive prostate cancer using an automated imaging platform for disease identification and measurement;European Journal of Hybrid Imaging;2023-04-03
3. Quantitative assessment of 99mTc-methylene diphosphonate bone SPECT/CT for assessing bone metastatic burden and its prognostic value in patients with castration-resistant prostate cancers: initial results in a single-center retrospective study;Annals of Nuclear Medicine;2023-03-22
4. A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases;European Journal of Cancer;2023-03
5. A computer program to assess the bone scan index for Tc-99m hydroxymethylene diphosphonate: Evaluation of jaw pathologies of patients with bone metastases using SPECT/CT;Diagnostic and Interventional Radiology;2023-01-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3